With regard to AD, no studies in humans have been initiated, but systemic delivery of CRISPR components in transgenic human APP mice showed robust indel formation in the brain, reduction in Aβ-associated pathologies, and improvement in cognitive performance.39 The gene discussed is APP; the disease is Alzheimer disease.